BSE filing, NSE: CEATLTD. Summary written from the filing by ALFA Finder's alert engine.
Ceat Ltd: key numbers
- Share price
- ₹3,140.50
- Market cap
- ₹12,703 Cr
- Revenue (annual)
- ₹15,678 Cr
- Net profit (annual)
- ₹698.0 Cr
- P/E (TTM)
- 24.6×Sector 31.4×
- Promoter holding
- 47.29%+0.00% QoQ
- FII holding
- 13.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ceat Ltd
All →Ceat Debt & Borrowing: ₹50 Cr
CEAT Limited confirmed redemption of its Rs. 50 Crore Commercial Paper on maturity dated October 23, 2026. The scheduled obligation was fulfilled on the same day.
- Value
- ₹50.00 Cr
Ceat Other Announcement
CEAT Ltd disclosed loss of three share certificates belonging to holder G Sudarshan Pal. NSDL notified the exchanges for member reference and duplicate issuance.
Ceat Earnings Call Transcript: Key Takeaways
Ceat achieved record quarterly revenue but margins are under pressure from rising input costs and currency depreciation. Management is aggressively expanding capacity while navigating a complex transition with the Camso acquisition.
Ceat Investor Presentation: Key Takeaways
CEAT reported Q2 FY27 revenue of Rs. 4,762 Cr, up 26.2% YoY, driven by healthy volume and realization growth across segments despite EBITDA margin contraction due to raw material costs.
Ceat Management Change
CEAT Limited has appointed Mr. Sumeet Narang as a Non-Executive Independent Director for a 5-year term, effective October 14, 2026.
Ceat Q2 FY27 Results: Net Profit ₹112 Cr, Down 39.8% YoY
Ceat Ltd reported revenue from operations of ₹4,762 Cr (+26.2% YoY) and net profit of ₹112 Cr (-39.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹112 Cr · -39.8% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.